{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:59:59Z","timestamp":1790269199982,"version":"4.1.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:00:00Z","timestamp":1790208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:00:00Z","timestamp":1790208000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurogenetics"],"DOI":"10.1007\/s10048-026-00944-w","type":"journal-article","created":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T03:51:04Z","timestamp":1790221864000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A rare ATM variant in a Colombian family with chorea-ataxia syndrome: implications for an early diagnosis"],"prefix":"10.1007","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2592-1749","authenticated-orcid":false,"given":"Viviana A.","family":"Mart\u00ednez-Villota","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3383-8566","authenticated-orcid":false,"given":"Malco","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-7525-3845","authenticated-orcid":false,"given":"Lucely","family":"Ortega-Bola\u00f1os","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,24]]},"reference":[{"issue":"9","key":"944_CR1","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1002\/mds.30302","volume":"40","author":"M Rossi","year":"2025","unstructured":"Rossi M, Stephen CD, Dam\u00e1sio J, Pedroso JL, Kuo SH, Lin CYR et al (2025) Unravelling the global tapestry of genetic ataxias: Epidemiology and genetic testing approaches. Mov Disord Off J Mov Disord Soc 40(9):1805\u20131820. https:\/\/doi.org\/10.1002\/mds.30302","journal-title":"Mov Disord Off J Mov Disord Soc"},{"issue":"9","key":"944_CR2","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1080\/1744666X.2020.1810570","volume":"16","author":"P Amirifar","year":"2020","unstructured":"Amirifar P, Ranjouri MR, Lavin M, Abolhassani H, Yazdani R, Aghamohammadi A (2020) Ataxia-telangiectasia: epidemiology, pathogenesis, clinical phenotype, diagnosis, prognosis and management. Expert Rev Clin Immunol 16(9):859\u2013871. https:\/\/doi.org\/10.1080\/1744666X.2020.1810570","journal-title":"Expert Rev Clin Immunol"},{"key":"#cr-split#-944_CR3.1","unstructured":"Veenhuis S, van Os N, Weemaes C, Kamsteeg EJ, Willemsen M Ataxia-Telangiectasia (1993) In: Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews\u00ae [Internet]. Seattle (WA): University of Washington, Seattle"},{"key":"#cr-split#-944_CR3.2","unstructured":"[cited 2026 Jan 12]. Available from: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK26468\/"},{"issue":"12","key":"944_CR4","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1212\/WNL.0000000000000794","volume":"83","author":"A M\u00e9neret","year":"2014","unstructured":"M\u00e9neret A, Ahmar-Beaugendre Y, Rieunier G, Mahlaoui N, Gaymard B, Apartis E et al (2014) The pleiotropic movement disorders phenotype of adult ataxia-telangiectasia. Neurology 83(12):1087\u20131095. https:\/\/doi.org\/10.1212\/WNL.0000000000000794","journal-title":"Neurology"},{"key":"944_CR5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.parkreldis.2017.12.009","volume":"46","author":"HAG Teive","year":"2018","unstructured":"Teive HAG, Camargo CHF, Munhoz RP (2018) More than ataxia - Movement disorders in ataxia-telangiectasia. Parkinsonism Relat Disord 46:3\u20138. https:\/\/doi.org\/10.1016\/j.parkreldis.2017.12.009","journal-title":"Parkinsonism Relat Disord"},{"issue":"8","key":"944_CR6","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1002\/mds.27319","volume":"33","author":"A Levy","year":"2018","unstructured":"Levy A, Lang AE (2018) Ataxia-telangiectasia: A review of movement disorders, clinical features, and genotype correlations. Mov Disord Off J Mov Disord Soc 33(8):1238\u20131247. https:\/\/doi.org\/10.1002\/mds.27319","journal-title":"Mov Disord Off J Mov Disord Soc"},{"issue":"4","key":"944_CR7","doi-asserted-by":"publisher","first-page":"524","DOI":"10.4067\/S0370-41062017000400013","volume":"88","author":"F Ruiz-Botero","year":"2017","unstructured":"Ruiz-Botero F, Rodr\u00edguez-Guerrero JT (2017) [New mutation in ATM gen in patient whith Ataxia Telangiectasia: Clinical case]. Rev Chil Pediatr 88(4):524\u2013528. https:\/\/doi.org\/10.4067\/S0370-41062017000400013","journal-title":"Rev Chil Pediatr"},{"issue":"4","key":"944_CR8","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1007\/s12026-024-09494-5","volume":"72","author":"RA Pereira","year":"2024","unstructured":"Pereira RA, Dantas EO, Loekmanwidjaja J, Mazzucchelli JTL, Aranda CS, Serrano MEG et al (2024) Ataxia-telangiectasia in Latin America: clinical features, immunodeficiency, and mortality in a multicenter study. Immunol Res 72(4):864\u2013873. https:\/\/doi.org\/10.1007\/s12026-024-09494-5","journal-title":"Immunol Res"},{"issue":"1","key":"944_CR9","doi-asserted-by":"publisher","first-page":"e19","DOI":"10.1212\/WNL.0000000000006700","volume":"92","author":"NJH van Os","year":"2019","unstructured":"van Os NJH, Hensiek A, van Gaalen J, Taylor AMR, van Deuren M, Weemaes CMR et al (2019) Trajectories of motor abnormalities in milder phenotypes of ataxia telangiectasia. Neurology 92(1):e19\u201329. https:\/\/doi.org\/10.1212\/WNL.0000000000006700","journal-title":"Neurology"},{"issue":"2","key":"944_CR10","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1002\/ana.25394","volume":"85","author":"K Schon","year":"2019","unstructured":"Schon K, van Os NJH, Oscroft N, Baxendale H, Scoffings D, Ray J et al (2019) Genotype, extrapyramidal features, and severity of variant ataxia-telangiectasia. Ann Neurol 85(2):170\u2013180. https:\/\/doi.org\/10.1002\/ana.25394","journal-title":"Ann Neurol"},{"issue":"3","key":"944_CR11","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1046\/j.1365-2249.2001.01452.x","volume":"123","author":"MA Garc\u00eda-P\u00e9rez","year":"2001","unstructured":"Garc\u00eda-P\u00e9rez MA, Allende LM, Corell A, Varela P, Moreno AA, Sotoca A et al (2001) Novel mutations and defective protein kinase C activation of T-lymphocytes in ataxia telangiectasia. Clin Exp Immunol 123(3):472\u2013480. https:\/\/doi.org\/10.1046\/j.1365-2249.2001.01452.x","journal-title":"Clin Exp Immunol"},{"issue":"10","key":"944_CR12","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1038\/gim.2017.37","volume":"19","author":"K Nykamp","year":"2017","unstructured":"Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY et al (2017) Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria. Genet Med Off J Am Coll Med Genet 19(10):1105\u20131117. https:\/\/doi.org\/10.1038\/gim.2017.37","journal-title":"Genet Med Off J Am Coll Med Genet"},{"issue":"10","key":"944_CR13","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1002\/humu.23778","volume":"40","author":"A Fi\u00e9vet","year":"2019","unstructured":"Fi\u00e9vet A, Bellanger D, Rieunier G, Dubois d\u2019Enghien C, Sophie J, Calvas P et al (2019) Functional classification of ATM variants in ataxia-telangiectasia patients. Hum Mutat 40(10):1713\u20131730. https:\/\/doi.org\/10.1002\/humu.23778","journal-title":"Hum Mutat"},{"issue":"1","key":"944_CR14","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s13058-018-0951-9","volume":"20","author":"AL Renault","year":"2018","unstructured":"Renault AL, Mebirouk N, Fuhrmann L, Bataillon G, Cavaciuti E, Le Gal D et al (2018) Morphology and genomic hallmarks of breast tumours developed by ATM deleterious variant carriers. Breast Cancer Res BCR 20(1):28. https:\/\/doi.org\/10.1186\/s13058-018-0951-9","journal-title":"Breast Cancer Res BCR"},{"issue":"3","key":"944_CR15","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1111\/pai.13020","volume":"30","author":"P Amirifar","year":"2019","unstructured":"Amirifar P, Ranjouri MR, Yazdani R, Abolhassani H, Aghamohammadi A (2019) Ataxia-telangiectasia: A review of clinical features and molecular pathology. Pediatr Allergy Immunol Off Publ Eur Soc Pediatr Allergy Immunol 30(3):277\u2013288. https:\/\/doi.org\/10.1111\/pai.13020","journal-title":"Pediatr Allergy Immunol Off Publ Eur Soc Pediatr Allergy Immunol"},{"issue":"1","key":"944_CR16","doi-asserted-by":"publisher","first-page":"101243","DOI":"10.1016\/j.gim.2024.101243","volume":"27","author":"T Pal","year":"2025","unstructured":"Pal T, Schon KR, Astiazaran-Symonds E, Balma\u00f1a J, Foulkes WD, James P et al (2025) Management of individuals with heterozygous germline pathogenic variants in ATM: A clinical practice resource of the American College of Medical Genetics and Genomics (ACMG). Genet Med Off J Am Coll Med Genet 27(1):101243. https:\/\/doi.org\/10.1016\/j.gim.2024.101243","journal-title":"Genet Med Off J Am Coll Med Genet"},{"key":"944_CR17","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.2147\/JMDH.S295486","volume":"14","author":"SA McGrath-Morrow","year":"2021","unstructured":"McGrath-Morrow SA, Rothblum-Oviatt CC, Wright J, Schlechter H, Lefton-Greif MA, Natale VA et al (2021) Multidisciplinary management of ataxia telangiectasia: Current perspectives. J Multidiscip Healthc 14:1637\u20131644. https:\/\/doi.org\/10.2147\/JMDH.S295486","journal-title":"J Multidiscip Healthc"},{"issue":"7","key":"944_CR18","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/S1474-4422(26)00158-4","volume":"25","author":"K Martakis","year":"2026","unstructured":"Martakis K, Bremova-Ertl T, Bolton C, Foltan T, Del Mar Garcia Romero M, Gautschi M et al (2026) Safety and efficacy of levacetylleucine in ataxia-telangiectasia: a phase 3, randomised, double-blind, placebo-controlled crossover trial. Lancet Neurol 25(7):633\u2013644. https:\/\/doi.org\/10.1016\/S1474-4422(26)00158-4","journal-title":"Lancet Neurol"},{"issue":"6","key":"944_CR19","doi-asserted-by":"publisher","first-page":"2607","DOI":"10.1007\/s12311-024-01746-2","volume":"23","author":"A Mehri","year":"2024","unstructured":"Mehri A, Toosi MB, Tavasoli AR, Saberi-Karimian M (2024) The latest developments for the treatment of ataxia telangiectasia: A narrative review. Cerebellum 23(6):2607\u20132615. https:\/\/doi.org\/10.1007\/s12311-024-01746-2","journal-title":"Cerebellum"}],"container-title":["Neurogenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10048-026-00944-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10048-026-00944-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10048-026-00944-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:02:18Z","timestamp":1790265738000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10048-026-00944-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,24]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["944"],"URL":"https:\/\/doi.org\/10.1007\/s10048-026-00944-w","relation":{},"ISSN":["1364-6753"],"issn-type":[{"value":"1364-6753","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,24]]},"assertion":[{"value":"7 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Institutional Review Board at local institutions, and written informed consent was obtained prior to publication. We confirm that we have read the Journal\u2019s position on issues involved in ethical publication and affirm that this work is consistent with those guidelines.","order":1,"name":"Ethics","label":"Ethical compliance statement","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"1. Research project: A. Conception, B. Organization, C. Execution; 2. Manuscript preparation: A. Writing of the first draft, B. Review and critique VAMV: 1A,1B,1C, 2A LOB: 1A,1B,1C, 2A MR: 1A, 1B, 1C, 2A. 2B","order":3,"name":"Ethics","label":"Author roles","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"74"}}